International Clinical Trial: A single-arm, single-center, prospective clinical study of trastuzumab emtansine combined with GEMOX regimen as first-line treatment for advanced biliary system tumors

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117154) titled 'A single-arm, single-center, prospective clinical study of trastuzumab emtansine combined with GEMOX regimen as first-line treatment for advanced biliary system tumors' on Jan. 20.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Zhejiang Cancer Hospital

Condition: Advanced biliary tract tumors

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2019-08-28

Target Sample Size: Experimental group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=300563

Disclaimer: Curated by HT Syndication....